Tirzepatide has less breast milk excretion data than semaglutide
To view a copy of this licence, visit About this article Cite this article Suter, B., Rhodes, A., Bigeh, A
Menopause belly usually refers to the accumulation of visceral fat due to the decline of estrogen production during menopause
Post-GLP-1, serotonin may dip temporarily, leaving you vulnerable to comfort eating as your brain seeks a quick dopamine hit from sweets or snacks
Network meta-analyses suggest that higher-dose semaglutide (1 mg and 2 mg weekly) and tirzepatide (a dual GIP/GLP-1 receptor agonist) demonstrate superior A1c reductions compared to other agents in the class, with mean reductions of 1.52.0% or greater from baseline
Trulicity (dulaglutide) product information